Skip to main content
OpenTrials
Completed

NCT Number: NCT01953380

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dermatitis, Allergic Contact Dermatitis Dermatitis, Contact Eczema Hypersensitivity Hypersensitivity, Delayed Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hudmottagningen SUS

Lund, Skåne County, 22185, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with suspected contact allergy
  • Age above 18 years
  • Participants have given informed consent

Exclusion criteria

  • Mental or language disabilities

Treatment and study plan

extended information

Behavioral

Primary outcomes

  1. knowledge

    Time frame: one year after inclusion

    knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

Secondary outcomes

  1. clinical improvement

    Time frame: one year after inclusion

    assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

  2. quality of life

    Time frame: one year after inclusion

    assessed by questionnaire, Dermatology Life Quality Index (DLQI).

  3. effect on daily functioning

    Time frame: one year after inclusion

    assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and Dermatology Life Quality Index (DLQI).

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Registry information

Acronym: ISICA-13

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Oct 1, 2013
Registry last updated
Apr 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.